Fever on hospital admission is associated with increased disease severity and mortality in acute pancreatitis: a systematic review and meta-analysis
摘要
Acute pancreatitis (AP) is often accompanied by changes in body temperature (Tb), but whether and how Tb at hospital admission is associated with the outcome of the disease remained unclear. Previous studies showed contradictory results regarding its prognostic value, and no meta-analysis was performed.
MethodsIn this systematic review and meta-analysis, we searched the PubMed, Embase, and CENTRAL databases (from inception to April 25, 2024) for studies in adult AP patients with reported admission Tb and mortality rate or a disease severity marker. With a random-effects model, we calculated pooled proportion (for mortality) or pooled mean (for secondary outcomes) with 95% CI and compared them between febrile and afebrile subgroups. With meta-regression, we assessed the correlation between admission Tb and mortality or length of hospital stay (LOS).
ResultsWe found 26 eligible studies including data from 40,630 AP patients. The pooled mortality rate was higher (p < 0.001) in febrile patients (0.15, 95% CI 0.11–0.20; I2 = 40%) than in afebrile patients (0.05, 95% CI 0.03–0.09; I2 = 98%). LOS was longer (p = 0.025) in the febrile subgroup (39.1 days, 95% CI 16.8–61.4; I2 = 91%) than in the afebrile subgroup (17.5 days, 95% CI 7.6–27.5; I2 = 96%). With meta-regression, admission Tb significantly and positively correlated with mortality (0.09, 95% CI 0.07–0.12) and LOS (16.5, 95% CI 5.6–27.5). The APACHE II score was significantly (p = 0.030) higher, while the SOFA score tended to be higher (p = 0.168) in the febrile than in the afebrile subgroup. Blood levels of amylase and C-reactive protein did not differ meaningfully between the groups.
ConclusionsFever on admission is associated with higher mortality, increased disease severity, and longer hospitalization in AP. High-quality studies with standardized Tb measurements are needed to determine the prognostic performance of admission Tb in AP.
Systematic review registrationThis study was registered with PROSPERO on 16 January 2020 (registration number: CRD42020139154).